Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$21.00 – $38.01
61% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $114.72B | $116.64B | $121.89B | $137.48B | $144.18B | $148.25B | $160.23B | $171.85B |
| Cost of revenue | $50.95B | $53.16B | $49.95B | $50.19B | $55.98B | $50.23B | $51.12B | $57.82B |
| Gross profit | $63.76B | $63.48B | $71.93B | $87.29B | $88.19B | $98.02B | $109.11B | $114.02B |
| Gross margin | 55.6% | 54.4% | 59.0% | 63.5% | 61.2% | 66.1% | 68.1% | 66.4% |
| R&D | $16.70B | $13.99B | $16.10B | $22.86B | $24.14B | $31.68B | $34.34B | $36.94B |
| Operating income | $20.64B | $21.67B | $26.13B | $32.95B | $30.05B | $31.39B | $35.45B | $33.24B |
| EBITDA | $24.96B | $25.91B | $29.68B | $38.01B | $35.67B | $36.29B | $42.30B | $39.91B |
| Net income | $16.30B | $16.87B | $19.54B | $24.99B | $22.81B | $25.85B | $32.56B | $29.91B |
| Net margin | 14.2% | 14.5% | 16.0% | 18.2% | 15.8% | 17.4% | 20.3% | 17.4% |
| EPS (diluted) | 242.03 | 250.41 | 290.11 | 370.97 | 338.70 | 383.82 | 483.26 | 444.19 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $190.2B | $408.08 | $371.32–$446.26 | 1 |
| 2028 | $186.9B | $231.89 | $211.00–$253.58 | 1 |
| 2029 | $202.5B | $201.81 | $183.63–$220.69 | 1 |
| 2030 | $252.9B | $377.81 | $343.77–$413.16 | 1 |
Forward consensus · source: Financial Modeling Prep
NIPPON SHINYAKU CO LTD
No one on the platform currently holds NPNKF.
No tracked institution reports a position in NPNKF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $62.0000 | |
| 2026-09-30 | $62.0000 | |
| 2026-03-31 | $62.0000 | 2026-06-29 |
| 2025-09-30 | $62.0000 | 2025-12-05 |
| 2025-03-31 | $62.0000 | 2025-06-30 |
| 2024-09-30 | $62.0000 | 2024-12-05 |
| 2024-03-28 | $62.0000 | 2024-06-28 |
| 2023-09-29 | $62.0000 | 2023-12-05 |
No one on the platform has traded NPNKF yet.
| +2.00% |
| $1.8B |
| — |
| KSPHFKissei Pharmaceutical Co., Ltd. | $25.77 | +0.00% | $1.1B | — |
| LJUIFSSY Group Limited | $0.40 | +0.00% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.